Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-03-15
1989-05-30
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544278, C07D49100, A61K 31505
Patent
active
048351571
ABSTRACT:
Novel thienopyrimidine-2,4-dione piperidine derivatives and novel furo[3,4-d]pyrimidine-2,4-dione piperidine derivatives are described. The novel piperidine derivatives are selective serotonin antagonists and alpha adrenergic blocking agents with cardiovascular, gastrointestinal and central nervous system activites.
REFERENCES:
patent: 4670560 (1987-06-01), Press et al.
patent: 4703120 (1987-10-01), Press
patent: 4707550 (1987-11-01), Press et al.
Kaplan, Arch. Intern. Med., vol. 143, 1983, pp. 255-259.
Royal Society of Medicine International Congress and Symposium Series, Rawlins et al., 1981, No. 41.
Buhler et al., Journal of Cardiovascular Pharmacology, vol. 7, Supplement 7, 1985.
Houston et al., Drugs, vol. 31, pp. 149-163, (1986).
Janssen, TIPS Reviews, 4, No. 198, 1983.
Janssen, Journal of Cardiovascular Pharmacology, No. 7, Suppl. 7, pp. 52-511, 1985.
Press Jeffery B.
Russell Ronald K.
Ford John M.
Lambert Benjamin F.
Ortho Pharmaceutical Corporation
Whittenbaugh Robert C.
LandOfFree
Thieno- and furopyrimidine-2,4-dione piperidine derivatives as s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thieno- and furopyrimidine-2,4-dione piperidine derivatives as s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thieno- and furopyrimidine-2,4-dione piperidine derivatives as s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2152773